BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

BioXcel Therapeutics had revenue of $1.10M in the quarter ending June 30, 2024, with 141.58% growth. This brings the company's revenue in the last twelve months to $2.40M, up 131.50% year-over-year. In the year 2023, BioXcel Therapeutics had annual revenue of $1.38M with 268.00% growth.

• Revenue (ttm): $2.40M
• Revenue Growth: +131.50%
• P/S Ratio: 7.42
• Revenue / Employee: $32,473
• Employees: 74
• Market Cap: 22.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.